-transparent.png){kind=logo}
Immunosuppression with Cs regimens has not significantly altered infection patterns relative to earlier modalities. However, reports of increased infection, especially with CMV/PCC, are not borne out in our experience both in numbers and timing of infections. Patients on low-dose Cs immunosuppression do continue to acquire infectious complications but, in general, rarely will lose their grafts or lives.
Related Publications
M B Sender, and
H J Ward, and
R J Glassock, and
J Rajfer, and
M A Koyle
November 2000,
Transplantation proceedings,
M B Sender, and
H J Ward, and
R J Glassock, and
J Rajfer, and
M A Koyle
August 1985,
Transplantation proceedings,
M B Sender, and
H J Ward, and
R J Glassock, and
J Rajfer, and
M A Koyle
June 1996,
Transplantation proceedings,
M B Sender, and
H J Ward, and
R J Glassock, and
J Rajfer, and
M A Koyle
September 1999,
The Journal of urology,
M B Sender, and
H J Ward, and
R J Glassock, and
J Rajfer, and
M A Koyle
January 1985,
Acta haematologica,
M B Sender, and
H J Ward, and
R J Glassock, and
J Rajfer, and
M A Koyle
August 1999,
Clinical transplantation,
M B Sender, and
H J Ward, and
R J Glassock, and
J Rajfer, and
M A Koyle
August 1994,
Clinical transplantation,
M B Sender, and
H J Ward, and
R J Glassock, and
J Rajfer, and
M A Koyle
February 1991,
The Journal of urology,
M B Sender, and
H J Ward, and
R J Glassock, and
J Rajfer, and
M A Koyle
February 1987,
Transplantation proceedings,
M B Sender, and
H J Ward, and
R J Glassock, and
J Rajfer, and
M A Koyle
January 1988,
Transplantation,
